Literature DB >> 19023552

[Prognostic factors for oral squamous cell carcinoma].

A W Eckert1, M H W Lautner, R Dempf, J Schubert, U Bilkenroth.   

Abstract

The aim of the present study was to analyze different prognostic factors to calculate the overall survival in oral squamous cell carcinoma (OSCC). Samples retrospectively collected from 99 patients with primary OSCC were analyzed with regard to tumor node metastasis stage, grading, and 5-year survival time and summarized at an SPSS 11.0 databank. Treated were 72 men and 27 women (average age 59 years) due to oral squamous cell carcinoma. A general 5-year survival time of 57.3% was found. Patient survival depended on tumor size and the extent of lymph node metastasis: survival was 80.1% (n=23) for T1 tumors and only 16.2% (n=28) for T4 tumors, 68.7% (n=55) at the N0 stage and 42.8% at >N0 (n=44, chi(2) test P=0.01, Fischer's exact test P=0.014). Highly differentiated carcinomas (n=26) had a survival probability of 78.9% and G2 and G3 tumors of only 48.9% (n=73, chi(2) test P<0.001). Tumor size and lymph node metastases are decisive.

Entities:  

Mesh:

Year:  2009        PMID: 19023552     DOI: 10.1007/s00104-008-1647-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  25 in total

Review 1.  Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer.

Authors:  Chandra B Tripathy; Nilanjan Roy
Journal:  Head Neck       Date:  2006-03       Impact factor: 3.147

2.  Oral malignant neoplasia: a survey of 428 cases in two Zimbabwean hospitals.

Authors:  M M Chidzonga
Journal:  Oral Oncol       Date:  2005-10-26       Impact factor: 5.337

3.  Oral cancer--the forgotten disease.

Authors:  L H Meskin
Journal:  J Am Dent Assoc       Date:  1994-08       Impact factor: 3.634

Review 4.  Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.

Authors:  Phillipe Lothaire; Evandro de Azambuja; Didier Dequanter; Yassine Lalami; Christos Sotiriou; Guy Andry; Gilberto Castro; Ahmad Awada
Journal:  Head Neck       Date:  2006-03       Impact factor: 3.147

5.  Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults.

Authors:  Keum-Kang Choi; Myung-Jin Kim; Pil-Young Yun; Jong-Ho Lee; Hyock-Soo Moon; Tae-Rim Lee; Hoon Myoung
Journal:  Oral Oncol       Date:  2005-10-24       Impact factor: 5.337

Review 6.  Epidemiology and prevention of oral cancer.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Levi; G Corrao; E Negri
Journal:  Oral Oncol       Date:  1997-09       Impact factor: 5.337

7.  Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients.

Authors:  Kolja Freier; Michael Engel; Katja Lindel; Christa Flechtenmacher; Joachim Mühling; Stefan Hassfeld; Christof Hofele
Journal:  Oral Oncol       Date:  2007-03-09       Impact factor: 5.337

8.  The incidence of p53 mutations increases with progression of head and neck cancer.

Authors:  J O Boyle; J Hakim; W Koch; P van der Riet; R H Hruban; R A Roa; R Correo; Y J Eby; J M Ruppert; D Sidransky
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

Review 9.  Epidemiology of cancer by tobacco products and the significance of TSNA.

Authors:  P C Gupta; P R Murti; R B Bhonsle
Journal:  Crit Rev Toxicol       Date:  1996       Impact factor: 5.635

10.  Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors.

Authors:  Thomas Kuhnt; Axel Becker; Marc Bloching; Johannes Schubert; Gunther Klautke; Rainer Fietkau; Juergen Dunst
Journal:  Med Oncol       Date:  2006       Impact factor: 3.738

View more
  2 in total

1.  Human telomerase reverse transcriptase protein expression is associated with survival in patients with oral squamous cell carcinoma.

Authors:  Kazuya Haraguchi; Manabu Habu; Naomi Yada; Masaaki Sasaguri; Izumi Yoshioka; Kazuhiro Tominaga
Journal:  Int J Clin Exp Pathol       Date:  2022-01-15

2.  Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions.

Authors:  Alexander Gröbe; Lena Rybak; Gerhard Schön; Ralf Smeets; Silke Tribius; Philippe Schafhausen; Till S Clauditz; Henning Hanken; Max Heiland
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-27       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.